Skip to content
Angiocrine Bioscience Logo
  • ABOUT US
    • OUR STORY
    • EXECUTIVE LEADERSHIP
    • OUR TEAM
    • BOARD OF DIRECTORS
    • SCIENTIFIC ADVISORY BOARD
    • CAREERS
  • SCIENCE
  • PIPELINE
  • NEWS & EVENTS
    • EVENTS
    • PRESS RELEASES
    • PUBLICATIONS
    • SUBSCRIBE
  • CONTACT US

Product_Cells_Website_482_naiveRef

Product_Cells_Website_482_naiveRef

John R.2014-04-15T21:28:41-07:00April 15th, 2014|

Share This Story, Choose Your Platform!

FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkEmail

Latest Publications

  • Open Label Dose Escalation Trial of AB-205 (E-CEL® cells) in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) March 14, 2021 12:51 pm
  • Results of an Open Label Dose Escalation Trial of AB-205 (E-CEL® cells) in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) February 8, 2021 12:50 pm
  • Results of a Phase 1 Open Label Dose Escalation Trial of AB-205 (Allogeneic Engineered Endothelial Cell Therapy) in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) December 5, 2020 12:44 pm
  • Endothelial transplantation rejuvenates aged hematopoietic stem cell function October 16, 2017 11:05 am
  • Conversion of adult endothelium to immunocompetent hematopoietic stem cells June 18, 2017 8:56 am
© Angiocrine Bioscience. All Rights Reserved. | Privacy Policy | Website Design by Webene, Inc.
Page load link
Our website uses necessary cookies to make it work. In addition, our website sues cookies to enhance your browsing experience and analyze our traffic. By clicking "Accept" you consent to our use of cookies. Accept Reject
Go to Top